The First Hospital of Jilin University-the Eastern Division
Welcome,         Profile    Billing    Logout  
 3 Trials 
5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zhu, Hui
NCT06300177: D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure

Recruiting
3
522
RoW
D-1553 Tablet, Docetaxel injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Non Small Cell Lung Cancer
10/26
12/27
NCT06020066: SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI

Recruiting
2
202
RoW
EGFR-TK Inhibitor, Stereotactic radiotherapy
Fudan University
Brain Metastases, Non-small Cell Lung Cancer
08/28
08/29
IMM01-04, NCT05833984: Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas

Recruiting
1b/2
309
RoW
IMM01, SIRPα Fc, Tislelizumab
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Solid Tumor, Classic Hodgkin Lymphoma
02/24
11/24
NCT06821685: Autologous Decidual-like Natural Killer Cells Therapy for Infertility or Adverse Pregnancy History

Recruiting
1
14
RoW
autologous decidual-like NK cells
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The University of Science and Technology of China
Abortion, Habitual, Infertility Unexplained, Embryo Implantation, Pre-Eclampsia
07/27
12/27
NCT05967325: SVF Combined With Functional Self-assembling Peptide Nanofiber Hydrogels in the Treatment of Spinal Cord Injury

Recruiting
N/A
15
RoW
Stromal Vascular Fraction (SVF) combined with Functional self-assembling peptide nanofiber hydrogels
Kunming Tongren Hospital
Safety Issues
07/24
07/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zhu, Hui
NCT06300177: D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure

Recruiting
3
522
RoW
D-1553 Tablet, Docetaxel injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Non Small Cell Lung Cancer
10/26
12/27
NCT06020066: SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI

Recruiting
2
202
RoW
EGFR-TK Inhibitor, Stereotactic radiotherapy
Fudan University
Brain Metastases, Non-small Cell Lung Cancer
08/28
08/29
IMM01-04, NCT05833984: Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas

Recruiting
1b/2
309
RoW
IMM01, SIRPα Fc, Tislelizumab
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Solid Tumor, Classic Hodgkin Lymphoma
02/24
11/24
NCT06821685: Autologous Decidual-like Natural Killer Cells Therapy for Infertility or Adverse Pregnancy History

Recruiting
1
14
RoW
autologous decidual-like NK cells
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The University of Science and Technology of China
Abortion, Habitual, Infertility Unexplained, Embryo Implantation, Pre-Eclampsia
07/27
12/27
NCT05967325: SVF Combined With Functional Self-assembling Peptide Nanofiber Hydrogels in the Treatment of Spinal Cord Injury

Recruiting
N/A
15
RoW
Stromal Vascular Fraction (SVF) combined with Functional self-assembling peptide nanofiber hydrogels
Kunming Tongren Hospital
Safety Issues
07/24
07/25

Download Options